Lynch syndrome: Lifetime Risk of Colorectal and Endometrial Cancers

A new study estimates the lifetime risks for colorectal and endometrial cancer in people with a genetic mutation for Lynch syndrome. The analysis was controlled to avoid bias and overestimating risk.

Even after adjusting for possible bias, lifetime risks for both cancers was high and the need for special surveillance was critical.

In 147 families with diagnosed Lynch syndrome (hereditary nonpolyposis colon cancer or HNPCC) there were 638 cases of colorectal cancer and 155 cases of endometrial cancer. All families had a mismatch repair (MMR) gene mutations (55 MLH1, 81 MSH2, and 11 MSH6).

For men in the study:

For women studied:

Elena Stoffel, MD,MPH, and her colleagues concluded,

Lifetime risks of CRC and EC in mismatch repair gene mutation carriers are high even after adjusting for ascertainment. These estimates are valuable for patients and providers; specialized cancer surveillance is necessary.

Another study in Canada that analyzed risk for colorectal cancer for families in Ontario with Lynch Syndrome found a 60 percent risk by age 70 for men and  a 47 percent risk for women.  Men who carried a MLH1 gene had a 67 percent risk, while women had a 35 percent risk.  By age 90 risk of having colorectal cancer increased to 81 percent for men and 72 percent for women.

Carriers of the MLH1 gene had a fairly consistent increase of risk over the general population over their lives.  They were about 5 times more likely to get colorectal cancer at any age.  However, relative risk decreased for MSH2 carriers.  At age 30, they were thirteen times more likely to have cancer, decreasing to about 5 percent at age 70.

SOURCES:  Stoffel et al., Gastroenterology, published online July 18, 2009.

Choi et al., Hereditary Cancer in Clinical Practice, published online August 23, 2009.

Bookmark and Share

This news article was originally posted on August 24th, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on August 24th, 2009
Tags: HNPCC, Lynch syndrome

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe